Zacks: Brokerages Expect OraSure Technologies, Inc. (OSUR) to Post $0.11 EPS

Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR) to post earnings of $0.11 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for OraSure Technologies’ earnings. OraSure Technologies reported earnings of $0.12 per share during the same quarter last year, which indicates a negative year over year growth rate of 8.3%. The business is scheduled to announce its next quarterly earnings report on Wednesday, February 6th.

According to Zacks, analysts expect that OraSure Technologies will report full year earnings of $0.32 per share for the current year, with EPS estimates ranging from $0.28 to $0.39. For the next financial year, analysts forecast that the firm will report earnings of $0.47 per share, with EPS estimates ranging from $0.43 to $0.49. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that follow OraSure Technologies.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, November 7th. The medical instruments supplier reported $0.13 EPS for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.02. The business had revenue of $45.90 million during the quarter, compared to the consensus estimate of $44.50 million. OraSure Technologies had a return on equity of 6.58% and a net margin of 9.49%. OraSure Technologies’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.09 earnings per share.

Several brokerages have commented on OSUR. TheStreet downgraded OraSure Technologies from a “b” rating to a “c+” rating in a research note on Thursday, November 8th. Zacks Investment Research downgraded OraSure Technologies from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 7th. ValuEngine raised OraSure Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, November 6th. BidaskClub raised OraSure Technologies from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 24th. Finally, Raymond James reissued a “mkt perform” rating on shares of OraSure Technologies in a research note on Tuesday, October 23rd. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $20.50.

In other OraSure Technologies news, Director Charles W. Patrick sold 8,000 shares of the business’s stock in a transaction dated Monday, August 27th. The stock was sold at an average price of $16.29, for a total transaction of $130,320.00. Following the completion of the transaction, the director now owns 54,298 shares of the company’s stock, valued at $884,514.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.90% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of OSUR. Point72 Asset Management L.P. acquired a new position in shares of OraSure Technologies in the second quarter valued at approximately $122,000. Cubist Systematic Strategies LLC acquired a new position in shares of OraSure Technologies in the first quarter valued at approximately $139,000. LPL Financial LLC acquired a new position in shares of OraSure Technologies in the third quarter valued at approximately $155,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of OraSure Technologies in the third quarter valued at approximately $165,000. Finally, Jane Street Group LLC acquired a new position in shares of OraSure Technologies in the third quarter valued at approximately $183,000. 93.13% of the stock is owned by hedge funds and other institutional investors.

NASDAQ OSUR traded down $0.37 during trading on Wednesday, hitting $12.58. 423,016 shares of the company’s stock were exchanged, compared to its average volume of 545,076. The company has a market cap of $826.26 million, a price-to-earnings ratio of 24.67, a PEG ratio of 3.41 and a beta of 1.52. OraSure Technologies has a fifty-two week low of $12.35 and a fifty-two week high of $22.22.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

Further Reading: What are trading strategies for the 52-week high/low?

Get a free copy of the Zacks research report on OraSure Technologies (OSUR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply